testosterone undecanoate

Known as: Androst-4-en-3-one, 17-((1-oxoundecyl)oxy)-, (17-beta), Testosterone 17Beta-Undecylate, testosterone undecylate 
The undecanoate ester form of the androgen testosterone, with gonadotropin-secretory inhibiting and hormone replacement activity. As testosterone… (More)
National Institutes of Health

Related topics

Related topics

23 relations

Narrower (3)

AndrodermAveedNebido

Broader (2)

AndrogensTestosterone
AndrostanesBreast Neoplasms, MaleCYP3A7 protein, humanCongestive heart failure
(More)

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2013
Highly Cited
2013
Testosterone deficiency is associated with increased risk of mortality and testosterone replacement improves survival in men with type 2 diabetes.
OBJECTIVE Men with type 2 diabetes are known to have a high prevalence of testosterone deficiency. No long-term data are… (More)
Is this relevant?
Highly Cited
2010
Highly Cited
2010
Effects of testosterone undecanoate on cardiovascular risk factors and atherosclerosis in middle-aged men with late-onset hypogonadism and metabolic syndrome: results from a 24-month, randomized…
INTRODUCTION Longitudinal studies have demonstrated that male hypogonadism could be considered a surrogate marker of incident… (More)
  • table 1
  • figure 1
  • table 3
  • figure 2
Is this relevant?
Highly Cited
2009
Highly Cited
2009
Multicenter contraceptive efficacy trial of injectable testosterone undecanoate in Chinese men.
CONTEXT Hormonal male contraceptive regimens effectively and reversibly suppress sperm production, but there are few large-scale… (More)
  • figure 1
  • table 1
  • figure 2
Is this relevant?
Highly Cited
2007
Highly Cited
2007
Androgen receptor gene CAG repeat length and body mass index modulate the safety of long-term intramuscular testosterone undecanoate therapy in hypogonadal men.
CONTEXT A reliable form of androgen substitution therapy regarding kinetics, tolerance, and restoration of androgenicity is… (More)
Is this relevant?
Highly Cited
2003
Highly Cited
2003
Testosterone supplementation in men with type 2 diabetes, visceral obesity and partial androgen deficiency.
The objective of this study was to assess the effects of oral testosterone supplementation therapy on glucose homeostasis… (More)
  • table 1
  • table 2
  • table 3
Is this relevant?
Highly Cited
2003
Highly Cited
2003
A multicenter contraceptive efficacy study of injectable testosterone undecanoate in healthy Chinese men.
This report describes a Phase II, multicenter, contraceptive efficacy clinical trial using monthly injections of testosterone… (More)
Is this relevant?
Highly Cited
2003
Highly Cited
2003
Oral testosterone supplementation increases muscle and decreases fat mass in healthy elderly males with low-normal gonadal status.
BACKGROUND Loss of muscle mass (sarcopenia) leads to frailty in older men. The decline in testosterone over the life span may… (More)
Is this relevant?
Highly Cited
1999
Highly Cited
1999
Repeated intramuscular injections of testosterone undecanoate for substitution therapy in hypogonadal men.
OBJECTIVE To investigate the suitability of intramuscular testosterone undecanoate (TU) injections for substitution therapy in… (More)
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
Highly Cited
1994
Highly Cited
1994
A ten-year safety study of the oral androgen testosterone undecanoate.
Testosterone undecanoate (Andriol) is an oral androgen that provides the hypogonadal patient with the unmodified testosterone… (More)
Is this relevant?
Highly Cited
1981
Highly Cited
1981
Androgen replacement with oral testosterone undecanoate in hypogonadal men: a double blind controlled study.
The effects of androgen withdrawal and replacement were investigated in six hypergonadotrophic and six hypogonadotrophic men with… (More)
Is this relevant?